These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17447409)

  • 21. Parkinson's disease. I.
    Mones RJ
    N Y State J Med; 1970 Nov; 70(21):2687-91. PubMed ID: 4919227
    [No Abstract]   [Full Text] [Related]  

  • 22. Mao-B inhibitor know-how: back to the pharm.
    Burke WJ
    Neurology; 2009 Dec; 73(23):2048; author reply 2048. PubMed ID: 19996086
    [No Abstract]   [Full Text] [Related]  

  • 23. MAO-B inhibitor know-how: back to the pharm.
    Lewitt PA
    Neurology; 2009 Apr; 72(15):1352-7. PubMed ID: 19365057
    [No Abstract]   [Full Text] [Related]  

  • 24. Notable Europeans with Parkinson's disease.
    Garcia de Yebenes JJ
    Adv Neurol; 1999; 80():467-70. PubMed ID: 10410757
    [No Abstract]   [Full Text] [Related]  

  • 25. Parkinson's disease over the last 100 years.
    Calne DB
    Adv Neurol; 2003; 91():1-8. PubMed ID: 12442659
    [No Abstract]   [Full Text] [Related]  

  • 26. Productivity and impact of the top 100 cited Parkinson's disease investigators since 1985.
    Sorensen AA; Weedon D
    J Parkinsons Dis; 2011; 1(1):3-13. PubMed ID: 23939254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease update.
    Friedman JH
    R I Med; 1993 Nov; 76(11):539-41. PubMed ID: 8312630
    [No Abstract]   [Full Text] [Related]  

  • 28. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetrahydropapaveroline in Parkinson's disease and alcoholism: a look back in honor of Merton Sandler.
    Collins MA
    Neurotoxicology; 2004 Jan; 25(1-2):117-20. PubMed ID: 14697886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early diagnosis of Parkinson's disease and initiation of treatment.
    Weiner WJ
    Rev Neurol Dis; 2008; 5(2):46-53; quiz 54-5. PubMed ID: 18660736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics.
    Fangmann P; Assion HJ; Juckel G; González CA; López-Muñoz F
    J Clin Psychopharmacol; 2008 Feb; 28(1):1-4. PubMed ID: 18204333
    [No Abstract]   [Full Text] [Related]  

  • 32. UK Parkinson's Excellence Network: time for a paradigm shift in Parkinson's care.
    Burn D; Boulicault D
    Neurodegener Dis Manag; 2015; 5(3):177-80. PubMed ID: 26107315
    [No Abstract]   [Full Text] [Related]  

  • 33. Bibliometric analysis on global Parkinson's disease research trends during 1991-2006.
    Li T; Ho YS; Li CY
    Neurosci Lett; 2008 Aug; 441(3):248-52. PubMed ID: 18582532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic biomarkers of Parkinson's disease.
    Williams A; Sturman S; Steventon G; Waring R
    Acta Neurol Scand Suppl; 1991; 136():19-23. PubMed ID: 1801532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropharmacology. Psychoactive smoke.
    Glassman AH; Koob GF
    Nature; 1996 Feb; 379(6567):677-8. PubMed ID: 8602211
    [No Abstract]   [Full Text] [Related]  

  • 36. Amine oxidation: the first 111 years. Concluding remarks.
    Tipton K
    Pharmacol Res Commun; 1988 Dec; 20 Suppl 4():63-72. PubMed ID: 3072569
    [No Abstract]   [Full Text] [Related]  

  • 37. Rasagiline as a therapy for Parkinson's disease (PD).
    Hermanowicz N
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):174-5; author reply 175-6. PubMed ID: 17719520
    [No Abstract]   [Full Text] [Related]  

  • 38. Linking SIRT2 to Parkinson's disease.
    Garske AL; Smith BC; Denu JM
    ACS Chem Biol; 2007 Aug; 2(8):529-32. PubMed ID: 17708669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for Parkinson's disease.
    Chen JJ; Swope DM
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):161S-173S. PubMed ID: 18041936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fifty years of Parkinson's disease: one step forwards, two steps back?
    Lewis SJ
    Br J Hosp Med (Lond); 2016 Oct; 77(10):560-564. PubMed ID: 27723396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.